RecruitingPhase 1Phase 2NCT06543823
ST250 as a Therapeutic Option for Head & Neck Reconstruction
The Use of Suprathel®250 as a Novel Therapeutical Option for Mucosal Healing in Head and Neck Surgery
Sponsor
Alaa Emara
Enrollment
60 participants
Start Date
Apr 30, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- recurrent episodes of tonsillar infection
Exclusion Criteria3
- children
- pregnant/ breastfeeding women
- patients undergoing chemo / radiotherapy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESupraTHEL 250
the membrane is placed onto the wound bed and fixed in place by resorbable interrupted sutures
OTHERComparator
no membrane is placed onto the wound bed , left bare to heal
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06543823
Related Trials
Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders
NCT056563653 locations
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
NCT055754014 locations
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
NCT063269831 location
Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
NCT065768301 location
Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy
NCT036250111 location